11月 2025
- 首頁
- Genomind
11月 2025Genomind的市場佔有率分析
Your Medication Management Partner Unlocking better outcomes through precision health technology. View Solutions Evolving how we prescribe medicine Our understanding of genetics is changing how we prescribe. As the science of medicine evolves, we feel a responsibility to deliver solutions that keep pace with that change.Our innovative, precision health technology can unlock the ability to
Genomind(包含公司地區)
查看更多網站流量與參與度資訊- genomind.com
Genomind截至 11月 2025 的總收入為 25M - 50M
Genomind 熱門網域產生的總收入
Genomind 熱門網域 3 年內的總收入
Genomind 熱門網域的總收入
Genomind的熱門網域總造訪量
了解Genomind市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Genomind的熱門網域平均造訪時長
分析Genomind參與度指標。
過去 3 個月平均造訪時長
子公司細目
Genomind的熱門網域平均頁面瀏覽量
了解Genomind如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Genomind
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Genomind, Inc. partners with Shore Quality Partners CIN.Genomind, a provider of population health management solutions and genetic testing for medication management, has partnered with Shore Quality Partners (SQP), an Accountable Care Organization (ACO) serving 28,000 Medicaid members of Somers Point, NJ and surrounding communities.
12月 1, 2022閱讀更多
新聞Genomind, Inc. partners with Parkview Regional Medical Center.Genomind, a provider of genetic testing and population health management solutions for medication management, has partnered with Parkview Physicians Group – Psychiatry in Fort Wayne, Indiana, to complete an interface for laboratory orders and results with Parkview’s Epic electronic health record (EHR) system.
8月 8, 2022閱讀更多
新聞Genomind, Inc. hires David Nash as member of Scientific Advisory Board.Genomind®, a leading precision healthcare company, has named David Nash, MD, MBA the newest member of its Scientific Advisory Board (SAB).
11月 9, 2021閱讀更多
查看所有Genomind信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。